General Information of This Metabolic Reaction (MR) (ID: MR000419)
Formula Reactant BPI-2009 Product BPI-2009 metabolite M16
Reactant Info Product Info
Metabolic Type Reduction - Reduction
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR000421 BPI-2009 BPI-2009 metabolite M11 Oxidation - Hydroxylation BPI-2009 [1]
MR000420 BPI-2009 BPI-2009 metabolite M4 Oxidation - Oxidation BPI-2009 [1]
MR000422 BPI-2009 BPI-2009 metabolite M6 Oxidation - Oxidation BPI-2009 [1]
MR000423 BPI-2009 BPI-2009 metabolite M7 Oxidation - Oxidation BPI-2009 [1]
MR000424 BPI-2009 BPI-2009 metabolite M8 Oxidation - Oxidation BPI-2009 [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR000418 BPI-2009 metabolite M16 BPI-2009 metabolite M15 Oxidation - Dehydroxyethylation BPI-2009 [1]
References
1 Metabolic pathway of icotinib in vitro: the differential roles of CYP3A4, CYP3A5, and CYP1A2 on potential pharmacokinetic drug-drug interaction. J Pharm Sci. 2018 Apr;107(4):979-983.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.